FDA grants Breakthrough Therapy status for a promising new drug targeting the rare and fatal Sanfilippo Syndrome Type B.
The strategic partnership for 6 gigawatts of GPU deployment challenges Nvidia's dominance and signals a new era in AI infrastructure.
The biotech firm secured its sixth approval for the ZORYVE franchise, expanding its dermatology treatment to children as young as two.
The all-stock deal marks a significant move in the ongoing consolidation wave among U.S. regional banks, creating a new top-ten lender.
Despite a revenue beat, the semiconductor equipment supplier's net loss and missed earnings per share estimates sent shares tumbling in after-hours trading.
Taiwan Semiconductor hits a 52-week high while AMD and OpenAI announce a landmark chip deal, signaling sustained bullish momentum for chipmakers.
The executive search firm's shares jumped over 19% after agreeing to an all-cash acquisition by an investor group led by Advent International and Corvex.
All-stock transaction marks significant consolidation in the regional banking sector, creating the 9th largest U.S. bank by assets.